{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2021-N-0862\" and posted_year = 2022 sorted by posted_date descending", "rows": [["FDA-2021-N-0862-0177", "FDA", "FDA-2021-N-0862", "FDA Listening Session with APhA Stakeholders--High-Level Notes", "Other", "Meeting Exhibits", "2022-11-22T05:00:00Z", 2022, 11, "2022-11-22T05:00:00Z", "2022-11-26T04:59:59Z", "2022-11-22T20:15:53Z", null, 0, 0, "09000064854fc3fd"], ["FDA-2021-N-0862-0140", "FDA", "FDA-2021-N-0862", "Nonprescription Drug Product With an Additional Condition for Nonprescription Use; Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2022-10-24T04:00:00Z", 2022, 10, "2022-10-24T04:00:00Z", null, "2022-11-22T18:58:05Z", "2022-23033", 0, 0, "090000648544cb97"], ["FDA-2021-N-0862-0043", "FDA", "FDA-2021-N-0862", "Request for Extension from Consumer Healthcare Products Association", "Other", "Request for Extension", "2022-10-06T04:00:00Z", 2022, 10, "2022-10-06T04:00:00Z", null, "2022-11-22T18:57:53Z", null, 0, 0, "09000064853bd957"], ["FDA-2021-N-0862-0039", "FDA", "FDA-2021-N-0862", "Request for Extension from American Pharmacists Association", "Other", "Request for Extension", "2022-09-26T04:00:00Z", 2022, 9, "2022-09-26T04:00:00Z", null, "2022-11-22T18:57:40Z", null, 0, 0, "090000648536e90d"], ["FDA-2021-N-0862-0001", "FDA", "FDA-2021-N-0862", "Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2022-06-28T04:00:00Z", 2022, 6, "2022-06-28T04:00:00Z", "2022-11-26T04:59:59Z", "2024-08-23T01:00:37Z", "2022-13309", 0, 0, "09000064851a6c55"], ["FDA-2021-N-0862-0008", "FDA", "FDA-2021-N-0862", "Reference 6- Engelberg Expert Workshop--Exploring Implications of the Nonprescription Drug Safe Use Regulatory Expansion Initiative on Reimbursement and Access_2013  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:48:58Z", null, 0, 0, "09000064851a6e08"], ["FDA-2021-N-0862-0011", "FDA", "FDA-2021-N-0862", "Reference 9 - 70 FR 52050  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:46:47Z", null, 0, 0, "09000064851a6e05"], ["FDA-2021-N-0862-0004", "FDA", "FDA-2021-N-0862", "Reference 2-  Journal of Research in Pharmacy Practice re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:32:38Z", null, 0, 0, "09000064851a6e07"], ["FDA-2021-N-0862-0010", "FDA", "FDA-2021-N-0862", "Reference 8- 83 FR 13394  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:45:35Z", null, 0, 0, "09000064851a6e03"], ["FDA-2021-N-0862-0009", "FDA", "FDA-2021-N-0862", "Reference 7- FDA Preliminary Regulatory Impact Analysis_Initial Regulatory Flexibility Analysis Unfunded Mandates Reform Act Analysis  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:43:52Z", null, 0, 0, "09000064851a6e04"], ["FDA-2021-N-0862-0005", "FDA", "FDA-2021-N-0862", "Reference 3- Guidance for Industry Label Comprehension Studies for Nonprescription Drug Products  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:34:10Z", null, 0, 0, "09000064851a56d6"], ["FDA-2021-N-0862-0007", "FDA", "FDA-2021-N-0862", "Reference 5- Engelberg Expert Workshop--Innovative Technologies and Nonprescription Medications--Addressing Undertreated Diseases and Conditions through Technology Enabled Self-Care  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:39:56Z", null, 0, 0, "09000064851a6e0a"], ["FDA-2021-N-0862-0003", "FDA", "FDA-2021-N-0862", "Reference 1- Guidance for Industry Self-Selection Studies for Nonprescription Drug\nProducts  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:30:20Z", null, 0, 0, "09000064851a56d8"], ["FDA-2021-N-0862-0013", "FDA", "FDA-2021-N-0862", "Reference 11 - 83 FR 33938  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:49:29Z", null, 0, 0, "09000064851a6e02"], ["FDA-2021-N-0862-0002", "FDA", "FDA-2021-N-0862", "Reference List re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:28:40Z", null, 0, 0, "09000064851a56d7"], ["FDA-2021-N-0862-0006", "FDA", "FDA-2021-N-0862", "Reference 4- Engleberg Expert Workshop--Nonprescription Medications With Conditions of Safe Use as a Novel Solution for Undertreated Diseases or conditions  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:38:18Z", null, 0, 0, "09000064851a6e06"], ["FDA-2021-N-0862-0012", "FDA", "FDA-2021-N-0862", "Reference 10 - 77 FR 12059  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:49:16Z", null, 0, 0, "09000064851a6e09"]], "truncated": false, "filtered_table_rows_count": 17, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2021-N-0862", "p1": "2022"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022", "results": [{"value": "FDA", "label": "FDA", "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022", "results": [{"value": 2022, "label": 2022, "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-0862&posted_year=2022&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 899.840195896104, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}